Adults:For the mangement of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.For the prevention and treatment of post-operative nausea and vomiting (PONV).Paediatric Population:For the mangement of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥ 6 months, and for the prevention and treatment of PONV in children aged ≥ 1 month.